Episode 24: Costs of adverse events in Renal Cell Carcinoma

https://is1-ssl.mzstatic.com/image/thumb/Podcasts114/v4/8a/61/9e/8a619eda-4370-c5a1-6a8d-8ed30aac4c4f/mza_12824525197888336905.jpg/600x600bb.jpg

Checkpoint NOW

Afreen Shariff

32 episodes

1 week ago

All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.

Medicine

Health & Fitness

RSS

All content for Checkpoint NOW is the property of Afreen Shariff and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/7711112/7711112-1605830906092-4f856047119d3.jpg

Episode 24: Costs of adverse events in Renal Cell Carcinoma

Checkpoint NOW

25 minutes 19 seconds

2 years ago

Episode 24: Costs of adverse events in Renal Cell Carcinoma

Learn from the experts about the costs associated with irAEs in patients treated for Renal Cell Carcinoma. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts- medical Oncologists Dr. Daniel Geynisman and Dr. Bradley McGregor, MD for an informative and high yield discussion regarding real and hidden costs of adverse events and how this impacts patients.